Skip to main content
Porto

PMMNG logo

  • Home
  • News
  • Our Meetings
    • Monthly PMMNG Meetings
    • Steering Committee Meetings
  • Myeloma Events
    • Upcoming Events
    • Archived Myeloma Events
  • Our Members
  • Miles for Myeloma
  • Resources
    • Myeloma Education Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

Archived Events
  • CureTalks: CRISPR-edited Immune Cells Enhance Fight Against Blood Cancers
  • CancerCare: Update on CAR T-Cell Therapies
  • IMF: How to Optimize and Protect your Immune System: A Nutrition Approach
  • MMRF: Expert Session - Latest Updates on CAR-T Therapy and Bispecific Antibodies in MM
  • IMF: Patient & Family Webinar - The Future is Looking Bright for Myeloma Patients!
  • BMT: 2021 National Celebrating a Second Chance at Life Survivorship Symposium
  • Myeloma Crowd: The First FDA CAR T Approval (Abecma) for Relapsed or Refractory Myeloma
  • CancerCare: Taking Your Pills on Schedule - Why It Is So Important in Managing Cancer
  • April 2021 PMMNG Meeting - “Fighting Cancer with Your Fork” with Jacqueline Stulb
  • Myeloma Crowd: Myeloma Crowd Roundtable - BCMA and Other Targets

Myeloma Crowd: The First FDA CAR T Approval (Abecma) for Relapsed or Refractory Myeloma

Myeloma Crowd logoWhat: Webcast audio recording (1:03:33)
When: Friday April 16, 2021 2:00pm ET
Where: Web

Access webcast recording

Tags
event
webcast
archived
abecma
car-t
ide-cel
clinical trials
Dr. Noopur Raje